V162I (p.Val162Ile) variant of AKT3 (Q9Y243)
V162I (p.Val162Ile) in AKT3 (Q9Y243) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
V162I (p.Val162Ile) variant details
- p.Val162Ile
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.